Search

everythinglearnresearchcommunity

for

Search:↓

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

Both vertical and transverse sections are useful for diagnosing alopecia, but using both methods together is best.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Centratherum anthelminticum seed extract effectively treats Polycystic Ovary Syndrome in rats.

Hair cell cloning could potentially rejuvenate shrinking hair follicles, allowing for lifelong hair maintenance.

More dermal papilla cells in hair follicles lead to larger, healthier hair, while fewer cells cause hair thinning and loss.

BMP signaling controls hair follicle size and cell growth by affecting cell cycle genes.

VEGF helps hair grow and determines follicle size by increasing blood vessel growth.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

The boy with woolly hair nevus had thinner hair and abnormal hair follicles, which improved with treatment but worsened when treatment stopped.

Hair follicle size and distribution vary significantly across different body sites.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

The study found that balding scalps have more thin hairs and larger oil glands, which might contribute to skin conditions related to hair loss.

Temporal triangular alopecia usually starts in early childhood and treatment with Minoxidil has limited effectiveness.

Different types of stem cells and their environments are key to skin repair and maintenance.

Androgens can both increase and decrease hair growth in different parts of the body.

Extracts improve hair growth in alopecia.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

Using minoxidil with laser therapy is more effective for female hair loss than minoxidil alone.

Ginsenoside CK, found in Panax ginseng, can prevent hair loss by controlling certain growth pathways and promoting hair follicle development.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.